<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04423952</url>
  </required_header>
  <id_info>
    <org_study_id>APHP200195</org_study_id>
    <secondary_id>2019-A00377-50</secondary_id>
    <nct_id>NCT04423952</nct_id>
  </id_info>
  <brief_title>Validity of the French Version of the Quality of Life Questionnaire COMQ12-FR</brief_title>
  <acronym>COMQ12-FR</acronym>
  <official_title>Validity of the French Version of the Quality of Life Questionnaire COMQ12-FR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The World Health Organization estimates that chronic otitis media could reach between 65 and&#xD;
      350 million people worldwide and thus be an important cause of medical consultation and&#xD;
      prescription drugs.&#xD;
&#xD;
      The medical care of chronic otitis is difficult, despite several medical and surgical&#xD;
      treatment options. Moreover this pathology is gladly recurrent.&#xD;
&#xD;
      The completion of a standardized questionnaire to track symptoms objectively over time is&#xD;
      fundamental to verify the efficacy of specific treatments and to compare treatments.&#xD;
&#xD;
      The quality of life measurement questionnaire related to chronic otitis media (COMQ-12) is a&#xD;
      new questionnaire, validated in English, to assist the physician in evaluating chronic otitis&#xD;
      media.&#xD;
&#xD;
      The objective of this study is to translate and validate the test in French in children.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The World Health Organization estimates that chronic otitis media could reach between 65 and&#xD;
      350 million people worldwide and thus be an important cause of medical consultation and&#xD;
      prescription drugs.&#xD;
&#xD;
      The medical care of chronic otitis is difficult, despite several medical and surgical&#xD;
      treatment options. Moreover this pathology is often recurrent.&#xD;
&#xD;
      The completion of a standardized questionnaire to track symptoms objectively over time is&#xD;
      fundamental to verify the efficacy of specific treatments and to compare treatments.&#xD;
&#xD;
      The quality of life measurement questionnaire related to chronic otitis media (COMQ-12) is a&#xD;
      new questionnaire, validated in English, to assist the physician in evaluating chronic otitis&#xD;
      media.&#xD;
&#xD;
      The original version of the COMQ12 questionnaire, in English, was developed by Phillips et&#xD;
      al.. The construction of this questionnaire was based on three other questionnaires : the&#xD;
      Chronic Ear Survey (CES), the Chronic Otitis Media Outcome-15 (COMOT-15), and the Chronic&#xD;
      Otitis Media-5 (COM-5). The initial validation of the English version of Phillips et al. was&#xD;
      evaluated with an alpha value of Cronbach to 0.889, which shows high internal consistency and&#xD;
      would allow its use in several reputed international centers of otology.&#xD;
&#xD;
      The objective of this study is to translate and validate the test in French in children.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reproducibility</measure>
    <time_frame>1 year</time_frame>
    <description>Reproducibility of the questionnaire completed by a subject at 15 days apart. Student t-test. COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Consistency reliability test</measure>
    <time_frame>1 year</time_frame>
    <description>Measure of efficiency. Comparison of questionnaires completed by patients and controls.&#xD;
COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Item-total Pearson correlation</measure>
    <time_frame>1 year</time_frame>
    <description>Measure of efficiency. Comparison of questionnaires completed by patients and controls.&#xD;
COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Principal components analysis</measure>
    <time_frame>1 year</time_frame>
    <description>Measure of efficiency. Comparison of questionnaires completed by patients and controls.&#xD;
COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Chronic Otitis Media</condition>
  <arm_group>
    <arm_group_label>Patients with chronic otitis media</arm_group_label>
    <description>Patients aged 7 to 15 years with chronic otitis media.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Minors aged 7 to 15 years, with no and no history of chronic otitis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>COMQ-12 questionnaire</intervention_name>
    <description>Subjects respond to COMQ-12 questionnaire twice at 15 days apart. COMQ-12 : quality of life measurement questionnaire related to chronic otitis media.</description>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_label>Patients with chronic otitis media</arm_group_label>
    <other_name>Patient questionnaire</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients followed by the department of otolaryngology and cervico-facial surgery of&#xD;
        Necker-Enfants Malades hospital and siblings for the control subjects.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Minors aged 7 to 15 years (inclusive)&#xD;
&#xD;
          -  Patients with chronic otitis media, united or bilateral&#xD;
&#xD;
          -  Controls: subjects without chronic otitis media or any other pathology of the ear at&#xD;
             the time of Inclusion or in background&#xD;
&#xD;
          -  holders of parental authority not opposed to participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Non-comprehension of french&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Françoise Denoyelle, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Françoise Denoyelle, MD, PhD</last_name>
    <phone>1 71 39 67 85</phone>
    <phone_ext>+33</phone_ext>
    <email>f.denoyelle@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hélène Morel</last_name>
    <phone>1 44 38 16 53</phone>
    <phone_ext>+33</phone_ext>
    <email>helene.morel@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Necker-Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Françoise Denoyelle, MD, PhD</last_name>
      <phone>1 71 39 67 85</phone>
      <phone_ext>+33</phone_ext>
      <email>f.denoyelle@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent Couloigner, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas Leboulanger, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François Simon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 5, 2020</study_first_submitted>
  <study_first_submitted_qc>June 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 26, 2021</last_update_submitted>
  <last_update_submitted_qc>June 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic otitis media in children</keyword>
  <keyword>Standardized quality of life measurement questionnaire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

